Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(66.7%)
Phase 3
1(33.3%)
3Total
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05392010Recruiting

Global BurdEn of MechanIcal VeNtilatIon (GEMINI). VeNtilatIon (GEMINI Study) 2022 for VENTILAGROUP.

Role: collaborator

NCT02836444Completed

Stratification of the Acute Respiratory Distress Syndrome - A Second Phase Study

Role: collaborator

NCT02352220Unknown

Determinants of Onset and Progression of COPD in Young Adults

Role: collaborator

NCT01599871Phase 3Completed

Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT02209974Phase 4Completed

Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD

Role: collaborator

NCT01595750Phase 4Unknown

Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease

Role: lead

NCT01141829Unknown

NADPH Oxidase Polymorphisms in Obstructive Sleep Apnea Syndrome (OSAS)

Role: collaborator

All 7 trials loaded